NDA 21788, held by Teva Womens. Estrogens, Conjugated Synthetic A.
As of Nov 14, 2026, NDA 21788 (Synthetic Conjugated Estrogens A), held by Teva Womens, was first approved by FDA on Nov 28, 2008, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 28, 2008 | Original applicationNew dosage form · Standard review | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Synthetic Conjugated Estrogens A0.625MG/GM · cream;vaginal | Estrogens, Conjugated Synthetic A | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
